Cookies

By selecting “Accept all” you expressly consent to our use of cookies for statistics and marketing. Google and Meta will learn that you are interested in a blood test, combine this with data from other websites into advertising profiles and also process it in the USA. Withdraw anytime in the footer.

Menopause and belly fat: Why the scale tells you too little

Dr. Andrej Busch
Dr. iur. · Founder & CEO, CHIRAYOU
Read Time8 minutes
Illustrative photo: Menopause and belly fat: Why the scale tells you too little

Many women gain weight around the middle in midlife, even though little has changed in their daily routine. A review on weight gain in midlife women in Current Obesity Reports (2024) explains this with falling energy expenditure and the hormonal changes of menopause, which shift more fat to the middle of the body. Measuring visceral fat therefore says more about this change than the scale does.

Key points at a glance

  • In midlife, energy expenditure and physical activity decline in women, and according to a review (Current Obesity Reports, 2024) both favour weight gain.
  • The hormonal changes of menopause alter fat distribution and increase the share of fat around the middle of the body.
  • A small cross-sectional study (Adipocyte, 2026) links poorer-functioning fat tissue under the skin in postmenopausal women to more visceral fat.
  • A position statement (Journal of Science and Medicine in Sport, 2021) describes that belly fat may respond to substantially less activity than weight loss requires.
  • A baseline and a re-test show whether the trend in belly fat is actually turning.

Why do women gain weight around the middle during menopause?

Midlife weight gain has mainly biological reasons: the body uses less energy, and hormones shift where it stores fat. The review in Current Obesity Reports names falling energy expenditure and declining physical activity as important causes. On top of that come the hormonal changes of menopause, which influence fat distribution and increase central adiposity, meaning fat around the middle of the body.

The authors sum it up this way: ageing, menopause and lifestyle act together and favour weight gain. For many women that is a relief. A woman who gains weight around the middle while eating the same as 10 years ago is experiencing a well-described remodelling of metabolism. It has little to do with a lack of discipline.

Why does fat in the abdomen matter more than the number on the scale?

The scale measures total weight, and that captures the inward shift of fat poorly. The review describes that midlife changes affect fat distribution and can be linked to health consequences: cardiovascular and metabolic diseases, joint wear (osteoarthritis), declining cognition, mental health strain and worse menopause symptoms.

Two values help sharpen the picture. Body fat percentage (Body Fat %) describes total fat relative to muscle mass. Visceral fat is the deep abdominal fat that surrounds the internal organs. Both can change independently of weight, which is why they tell a more precise story during menopause.

A position statement from Exercise and Sport Science Australia in the Journal of Science and Medicine in Sport (2021) supports this view for adults in general. It states that physical activity brings metabolic and cardiovascular benefits at any weight and irrespective of whether weight changes. Looking only at the scale may therefore miss exactly the progress that matters.

Why do some women build up more visceral fat after menopause than others?

One possible explanation lies in the quality of the fat tissue under the skin. A cross-sectional study of 54 adults in the journal Adipocyte (2026) examined 29 men and 25 postmenopausal women aged 30 to 70. The researchers took tissue samples from subcutaneous fat and assessed how well it works, among other things via the ratio of two messengers of fat tissue (adiponectin to leptin).

In the postmenopausal women, a less favourable ratio went along with larger fat cells, more inflammatory cells in the tissue, a measure of insulin resistance calculated from triglycerides and blood sugar, higher C-reactive protein (CRP, an inflammation value) and a larger visceral fat area. Inflammation and insulin resistance in subcutaneous fat were each independently linked to visceral fat. A statistical model suggested that the function of subcutaneous fat could precede visceral fat.

One way to picture it: the fat under the skin is the body's regular storage depot. When this depot works less well, that is linked in this study to more fat in the deep abdomen. The limits are clear: the study is small, captures a single point in time and examined a Mexican-Mestizo population, so the authors call for confirmation by prospective studies.

What can you do about belly fat during menopause?

The strongest levers are diet and physical activity, ideally started early. The review in Current Obesity Reports recommends early counselling on diet and physical activity to attenuate weight gain in midlife.

The Australian position statement gives concrete orders of magnitude for adults:

GoalWhat the position statement describes
Prevent gain in weight and fatmore than 150, preferably 300 minutes per week of aerobic activity of at least moderate intensity
Meaningful loss of weight and total fatat least 300 to 420 minutes per week of at least moderate intensity
Reduce belly fatevidence emerging, possibly substantially less activity needed than for weight loss
High-intensity training and resistance exerciseeffect on weight management still uncertain

The most important message for menopause sits in the third row: belly fat can move before the scale shows it. Staying motivated therefore takes a measurement that makes exactly this change visible.

Why does only a re-test show whether it works?

A single measurement is a snapshot; only the trajectory shows the direction. The review itself stresses that future research should follow weight trends in midlife over time, because trends say more than single values.

For you this means: a baseline at the start of the menopausal transition and a re-test after a few weeks show whether visceral fat and body fat percentage are moving in the desired direction. That way you spot a shift early, while it is still easy to influence.

When to see a doctor?

Talk to your doctor if your waist size or weight changes noticeably without a reason you can identify. The same applies if menopause symptoms weigh on you, if cardiovascular or metabolic diseases run in your family, or if measurements raise questions. Your doctor interprets the values and decides whether further examinations make sense.

How Chirayou can help

CHIRAYOU is a doctor-led online health program for preventive health. In the 90-day program, a smart scale using bioelectrical impedance measures your body fat percentage and your visceral fat as two separate markers. We score visceral fat as a signal of metabolic inflammation and body fat percentage as a measure of total fat load.

The at-home blood test complements this picture, with no clinic visit and no fasting. Among other markers, it measures triglycerides, apolipoprotein B (ApoB, the count of cholesterol-carrying particles that build up in artery walls), hsCRP as a marker of low-grade inflammation, and fructosamine, the average blood sugar over the prior 2 to 3 weeks.

A doctor discusses the results with you. From this comes a plan with 3 to 5 interventions, for example on movement and nutrition. After 90 days the next test follows (Test, Plan, Act), and in between, body fat percentage and visceral fat update weekly. That way you see whether the trend is turning. Your next step: start the CHIRAYOU 90-day program and set your baseline for the menopausal years.

The bottom line

During menopause, where the body stores fat shifts, and it happens even without changed habits. Visceral fat makes this shift visible, while the scale often does not. Measuring a baseline early, working specifically on movement and nutrition, and re-testing shows whether the trend is turning.

This article is for general information only and does not replace medical advice, diagnosis or treatment.

Frequently asked questions

Why am I gaining weight around the middle during menopause when I eat the same?

In midlife, energy expenditure and physical activity decline, and the hormonal changes of menopause shift fat to the middle of the body. A review in Current Obesity Reports (2024) describes this. Ageing, menopause and lifestyle act together. Unchanged eating habits can therefore lead to more belly fat over time, because the body uses less and stores fat differently.

What is the difference between body fat percentage and visceral fat?

Body fat percentage describes total body fat relative to muscle mass. Visceral fat is the deep abdominal fat that surrounds the internal organs. Both values can change independently of each other and independently of weight. CHIRAYOU measures them separately and scores visceral fat as a signal of metabolic inflammation, so the two values do not double-count.

How much exercise do I need to reduce belly fat?

The evidence is still emerging, but belly fat may respond to substantially less activity than weight loss requires. A position statement in the Journal of Science and Medicine in Sport (2021) states this for adults. To prevent gain in weight and fat, it names more than 150, preferably 300 minutes per week of moderate aerobic activity. Benefits for heart and metabolism arise at any weight.

Can I read my visceral fat from the scale?

A normal scale only shows total weight, which captures the shift of fat into the abdomen poorly. A smart scale with bioelectrical impedance also estimates visceral fat. The trajectory is most informative: a baseline and regular re-tests show whether belly fat is changing, even when weight stays the same.

References

  1. Hurtado MD, Saadedine M, Kapoor E, et al. (2024). Weight Gain in Midlife Women. Current obesity reports. pubmed.ncbi.nlm.nih.gov
  2. Medina-Urrutia A, Torre-Villalvazo I, Díaz-Villaseñor A, et al. (2026). The adiponectin/leptin ratio as a biomarker of adiposopathy and visceral adipose tissue accumulation: sex-specific mechanisms. Adipocyte. pubmed.ncbi.nlm.nih.gov
  3. Johnson NA, Sultana RN, Brown WJ, et al. (2021). Physical activity in the management of obesity in adults: A position statement from Exercise and Sport Science Australia. Journal of science and medicine in sport. pubmed.ncbi.nlm.nih.gov

Cookie settings

You decide for each purpose separately. Without your consent everything below stays off, and the website still works. By selecting “Accept all” or “Save selection” you consent to information being stored on and read from your device (Section 25(1) TDDDG) and to us and the providers named processing your data for the purposes you choose (Art. 6(1)(a) GDPR). For marketing you also expressly consent to Google or Meta learning that you are interested in a blood test or have ordered one (Art. 9(2)(a) GDPR). After you consent, we load the chosen services via Google Tag Manager from servers of Google Ireland Ltd., which receives your IP address. We remember your choice for 6 months and ask again sooner if purposes or providers change. You can withdraw your consent at any time here or via “Cookie settings” in the footer. Withdrawal takes effect from then on; processing before it remains lawful. More in our privacy policy.

Necessary

Stores your choice in this banner: cookie “lr_consent” (6 months, set by us; only version, choice and time, no identifier). Otherwise only where a function needs it: your language choice and the state of your order in your browser’s local storage (no identifier); in the checkout, the cookies “__stripe_mid” (1 year) and “__stripe_sid” (30 minutes) of our payment provider Stripe Payments Europe, Ltd. (Ireland) to prevent fraud; to protect against attacks and bots, the cookies “__cf_bm” (30 minutes) and “cf_clearance” (30 minutes) of our host Cloudflare, Inc. (USA), which also checks browser characteristics for this. Our own count of page views stores and reads nothing on your device and does not recognise you.

We analyse which pages are visited and which buttons are used, and we test variants of our pages (A/B tests), to improve the website. For this we use Google Analytics 4: Google receives your IP address, device and browser details, the pages and events you view and a random identifier, and processes the data on our behalf. For A/B tests our server assigns you to a test group and remembers it in a cookie.

Providers: CHIRAYOU GmbH (A/B tests), Google Ireland Limited, Ireland (processor)

Third country: Also processed in the USA (EU-US Data Privacy Framework, Art. 45 GDPR)

Cookies: _ga (6 months), _ga_N543GR4LNC (6 months), ch_abid (6 months), ch_ab_… (6 months)

Google Ads measures whether you order a blood test after clicking one of our ads, and uses this to serve, optimise and personalise ads. For this Google stores identifiers on your device and receives the pages you view (with their address), your IP address, device details and events such as starting and completing an order (with order value). Google processes these data as an independent controller also for its own purposes, combines them with other data about you, for example from your Google account and from other websites, and builds advertising profiles from them. In doing so Google learns that you are interested in a blood test or have ordered one. You hereby expressly consent to this processing (Art. 9(2)(a) GDPR).

Providers: Google Ireland Limited, Ireland (independent controller)

Third country: Also processed in the USA (EU-US Data Privacy Framework, Art. 45 GDPR)

Cookies: _gcl_au (90 days), _gcl_aw (90 days), _gcl_gb (90 days), _gcl_gs (90 days), _gcl_ls (local storage, no expiry), Google cookies on google.com/doubleclick.net, e.g. IDE (up to 13 months)

Meta (Facebook, Instagram) uses the Meta Pixel to measure whether you order a blood test or sign up for our newsletter after clicking one of our ads, and uses this to serve, optimise and personalise ads, including for people with similar characteristics. For this Meta stores identifiers on your device and receives the pages you view (with their address), your IP address, device details and these events (orders with order value), directly and also via the Meta Conversions API Gateway, which Meta runs on Amazon Web Services servers in the USA. Meta links the data to your Facebook or Instagram account and to data from other websites and builds advertising profiles from them. In doing so Meta learns that you are interested in a blood test or have ordered one. You hereby expressly consent to this processing (Art. 9(2)(a) GDPR). We and Meta are joint controllers for the collection and transmission; Meta alone is responsible for everything after that.

Providers: Meta Platforms Ireland Limited, Ireland (joint controller with us for collection and transmission)

Third country: Also processed in the USA (EU-US Data Privacy Framework, Art. 45 GDPR)

Cookies: _fbp (90 days), _fbc (90 days, only after clicking a Meta ad), Meta cookies on facebook.com, e.g. fr (90 days)